The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density.
Breast cancer
Cancer genomics
Journal
NPJ breast cancer
ISSN: 2374-4677
Titre abrégé: NPJ Breast Cancer
Pays: United States
ID NLM: 101674891
Informations de publication
Date de publication:
2020
2020
Historique:
received:
05
01
2020
accepted:
13
07
2020
entrez:
18
8
2020
pubmed:
18
8
2020
medline:
18
8
2020
Statut:
epublish
Résumé
Mammographic density (MD) influences breast cancer risk, but how this is mediated is unknown. Molecular differences between breast cancers arising in the context of the lowest and highest quintiles of mammographic density may identify the mechanism through which MD drives breast cancer development. Women diagnosed with invasive or in situ breast cancer where MD measurement was also available (
Identifiants
pubmed: 32802943
doi: 10.1038/s41523-020-00176-7
pii: 176
pmc: PMC7414106
doi:
Types de publication
Journal Article
Langues
eng
Pagination
34Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare no competing interests.
Références
J Pathol Clin Res. 2016 Jul 13;2(4):247-258
pubmed: 27840695
Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):456-63
pubmed: 20142244
Breast Cancer Res. 2003;5(5):R129-35
pubmed: 12927043
Cell Rep. 2018 Apr 03;23(1):239-254.e6
pubmed: 29617664
Breast Cancer Res. 2018 Feb 05;20(1):10
pubmed: 29402289
Nature. 2016 Mar 24;531(7595):471-475
pubmed: 26982726
Anticancer Res. 2011 Jun;31(6):2327-34
pubmed: 21737659
Nat Genet. 2018 Oct;50(10):1346-1348
pubmed: 30224651
Mol Clin Oncol. 2014 Jul;2(4):623-629
pubmed: 24940507
Ann Oncol. 2015 Feb;26(2):259-71
pubmed: 25214542
Breast Cancer Res. 2018 Jan 09;20(1):3
pubmed: 29316957
Breast Cancer Res Treat. 2010 Aug;123(1):245-55
pubmed: 20130984
Breast Cancer. 2018 May;25(3):259-267
pubmed: 29651637
Biomark Res. 2015 May 01;3:9
pubmed: 26015868
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13550-5
pubmed: 16141321
Ann Oncol. 2015 Aug;26(8):1533-46
pubmed: 25939896
Breast Cancer Res Treat. 2010 Jan;119(2):305-14
pubmed: 19241157
BMC Cancer. 2019 Jun 26;19(1):631
pubmed: 31242899
Genome Biol. 2015 Feb 27;16:49
pubmed: 25887352
Breast Cancer Res. 2018 Aug 9;20(1):92
pubmed: 30092832
Breast Cancer Res. 2013;15(5):R80
pubmed: 24020331
Nat Commun. 2016 May 10;7:11479
pubmed: 27161491
Cancer Res. 2012 Nov 1;72(21):5454-62
pubmed: 22933060
Cancer Res. 2006 Feb 1;66(3):1866-72
pubmed: 16452249
Biochim Biophys Acta. 2015 Apr;1855(2):276-300
pubmed: 25829250
Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2818-24
pubmed: 18843028
Br J Cancer. 2012 Nov 6;107(10):1776-82
pubmed: 23047548
Cancer Discov. 2012 Sep;2(9):826-39
pubmed: 22777768
Nat Commun. 2014 Oct 24;5:5303
pubmed: 25342443
J Pathol. 2019 Jun;248(2):243-252
pubmed: 30746706
Nat Genet. 2013 Oct;45(10):1127-33
pubmed: 24071851
BMC Cancer. 2015 Mar 18;15:143
pubmed: 25881232
Nat Genet. 2011 Mar;43(3):185-7
pubmed: 21278746
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1159-69
pubmed: 16775176
J Med Screen. 2009;16(3):140-6
pubmed: 19805755
Genet Med. 2019 Apr;21(4):913-922
pubmed: 30254378
N Engl J Med. 2002 Sep 19;347(12):886-94
pubmed: 12239257
Cancer Causes Control. 2015 Apr;26(4):621-6
pubmed: 25761408
Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1473-82
pubmed: 21610220
Breast Cancer Res. 2016 May 21;18(1):53
pubmed: 27209070
Nature. 2013 Feb 28;494(7438):492-496
pubmed: 23446422
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):343-9
pubmed: 15734956
Clin Case Rep. 2019 Jan 28;7(3):442-444
pubmed: 30899468